InvestorsHub Logo
Followers 123
Posts 8885
Boards Moderated 0
Alias Born 10/05/2004

Re: catty post# 415

Wednesday, 08/01/2018 9:20:46 AM

Wednesday, August 01, 2018 9:20:46 AM

Post# of 589
it all depends on whether they can secure other deals with big pharma. the one with nvo, assuming nvo gets approval, could bring in $100+ million in royalty revenue to EMIS alone. add that to other potential deals, the price target could be crazy high $20-$30+ but again, management is horrific so you never know.

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.